Dupilumab for Atopic Dermatitis During Pregnancy and Breastfeeding: A Case Report

Dupilumab for Atopic Dermatitis During Pregnancy and Breastfeeding: A Case Report

Saved in:

Bibliographic Details
Main Authors:	J.M. Alvarenga, A. Maria Lé, T. Torres
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Actas Dermo-Sifiliográficas
Online Access:	http://www.sciencedirect.com/science/article/pii/S0001731023008177
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Laboratory Changes During Dupilumab Treatment for Atopic Dermatitis
by: D. Flor, et al.
Published: (2025-05-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

[Artículo traducido] Dupilumab para la dermatitis atópica durante el embarazo y la lactancia: reporte de un caso
by: J.M. Alvarenga, et al.
Published: (2024-11-01)

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis
by: Mohamed A. Kamal, et al.
Published: (2024-11-01)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
by: Marco Ferrari, et al.
Published: (2023-01-01)

Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-09-01)

The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)

Comparative Analysis of the Efficacy of Abrocitinib and Dupilumab in the Treatment of Atopic Dermatitis
by: Song D, et al.
Published: (2025-04-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Predictors for the Efficacy of 4-Week Dupilumab Treatment in Atopic Dermatitis Patients
by: Yu L, et al.
Published: (2025-03-01)

Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01)

Dupilumab-induced psoriasis in a patient with atopic dermatitis successfully treated with Upadacitinib: A case report
by: Katrina D Cirone, et al.
Published: (2025-02-01)

High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01)

Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy
by: Jarmila Čelakovská, et al.
Published: (2025-01-01)

Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis
by: Paulina Stepinska, et al.
Published: (2025-12-01)

Management of patients with atopic dermatitis during pregnancy
by: E. A. Orlova, et al.
Published: (2021-07-01)

New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

A Case of Upadacitinib-Associated Ileus Secondary to Psoriasis Induced by Treatment of Atopic Dermatitis with Dupilumab
by: Liu X, et al.
Published: (2024-12-01)

Dupilumab in children and adolescents with atopic dermatitis, a 52-week real-life experience: first report in Colombia
by: Daniela Meléndrez Vásquez, et al.
Published: (2024-10-01)

Metabolomic and Lipidomic Alterations in Patients with Atopic Dermatitis with Dupilumab-Associated Ocular Surface Disease
by: VijayKumar Patra, et al.
Published: (2025-05-01)

New Opportunities of Dupilumab in Achieving Disease Control in Preschool Age Patients with Atopic Dermatitis: Clinical Case
by: Julia G. Levina, et al.
Published: (2024-09-01)

Dupilumab Efficacy and Safety in Severe Atopic Dermatitis in Children under 6 Years of Age: Two Clinical Cases
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01)

Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy
by: Jarmila Čelakovská, et al.
Published: (2024-12-01)

Efficacy and safety of dupilumab in patients with moderate-to-severe atopic dermatitis and comorbid allergic rhinitis
by: Tengfei Tian, et al.
Published: (2025-04-01)

Dupilumab-Induced Granuloma Annulare: A Challenging Adverse Effect of Atopic Dermatitis Treatment
by: Christeebella O. Akpala, et al.
Published: (2025-05-01)

Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-09-01)

T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab
by: Davender Redhu, et al.
Published: (2025-05-01)

Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
by: Francesca Barei, et al.
Published: (2024-12-01)

Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study
by: Mariele Morandin Lopes, et al.
Published: (2025-06-01)

An open-label interventional clinical study evaluating sweating function in dupilumab treatment for atopic dermatitis
by: Mai Matsumoto, et al.
Published: (2025-06-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Changes in skin barrier integrity by electrical impedance spectroscopy during dupilumab treatment on a child with severe atopic dermatitis
by: Elif Yaycı, et al.
Published: (2024-11-01)

Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China
by: Yue Xu, et al.
Published: (2025-07-01)

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
by: Jonathan I. Silverberg, et al.
Published: (2025-02-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]
by: Paolo Gisondi, et al.
Published: (2025-05-01)

Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01)

Recurrence and influencing factors of moderate-to-severe atopic dermatitis after dupilumab withdrawal: a retrospective cohort analysis
by: Maohua Chen, et al.
Published: (2025-08-01)

Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in Japan
by: Hidehisa Saeki, et al.
Published: (2025-07-01)